Cargando…
Theranostic applications of nanoparticles in neurodegenerative disorders
The preeminent treatments for neurodegenerative disease are often unavailable due to the poor accessibility of therapeutic drugs. Moreover, the blood–brain barrier (BBB) effectively blocks the transfer of cells, particles and large molecules, ie, drugs, across the brain. The most important challenge...
Autores principales: | Ramanathan, Sahana, Archunan, Govindaraju, Sivakumar, Muthusamy, Tamil Selvan, Subramanian, Fred, A Lenin, Kumar, Sundramurthy, Gulyás, Balázs, Padmanabhan, Parasuraman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154717/ https://www.ncbi.nlm.nih.gov/pubmed/30271147 http://dx.doi.org/10.2147/IJN.S149022 |
Ejemplares similares
-
MicroRNAs -the Next Generation Therapeutic Targets in Human Diseases
por: Srinivasan, Sakthivel, et al.
Publicado: (2013) -
Anticancer Potential of L-Histidine-Capped Silver Nanoparticles against Human Cervical Cancer Cells (SiHA)
por: Mohammed Asik, Rajmohamed, et al.
Publicado: (2021) -
Mollification of Doxorubicin (DOX)-Mediated Cardiotoxicity Using Conjugated Chitosan Nanoparticles with Supplementation of Propionic Acid
por: Siva, Durairaj, et al.
Publicado: (2022) -
Multi-functional nano silver: A novel disruptive and theranostic agent for pathogenic organisms in real-time
por: Gopinath, Ponnusamy Manogaran, et al.
Publicado: (2016) -
Theranostic Probes for Targeting Tumor Microenvironment: An Overview
por: Sikkandhar, Musafar Gani, et al.
Publicado: (2017)